These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A case of atypical eosinophilic pustular folliculitis that emerged following the administration of capecitabine. Takeuchi A; Nomura T; Kaku Y; Egawa G; Kabashima K J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e317-e318. PubMed ID: 29444365 [No Abstract] [Full Text] [Related]
3. Fixed Drug Eruption Late in the Course of Capecitabine Therapy. Del Rosario M; Tsai H; Dasanu CA Conn Med; 2016 Apr; 80(4):223-5. PubMed ID: 27265926 [TBL] [Abstract][Full Text] [Related]
4. Capecitabine-induced lichenoid drug eruption: a case report. Gehlhausen JR; Strausburg MB; Aouthmany M; Katona TM; Turner MJ Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329488 [TBL] [Abstract][Full Text] [Related]
5. Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine. Ljubojevic Hadzavdic S; Stulhofer Buzina D; Murtezani I; Skerlev M J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e304-e306. PubMed ID: 27987319 [No Abstract] [Full Text] [Related]
6. Eruptive nevi in a patient with metastatic breast cancer. Calleja-Algarra A; Aragón-Miguel R; Velasco-Tamariz V; Andrés-Lencina JJ; Prieto Barrios M; Maroñas Jiménez L; Ortiz Romero PL; Monsálvez Honrubia V Int J Dermatol; 2017 Dec; 56(12):1508-1509. PubMed ID: 28960262 [No Abstract] [Full Text] [Related]
7. Multiple inflammatory lesions in an oncology patient. Pigem R; Maroñas-Jiménez L; Pau-Charles I; Mascaró JM Int J Dermatol; 2016 Dec; 55(12):1301-1303. PubMed ID: 26710313 [No Abstract] [Full Text] [Related]
8. Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction. Demir S; Olgac M; Saglam S; Gelincik A; Colakoglu B; Buyukozturk S J Investig Allergol Clin Immunol; 2016; 26(1):66-7. PubMed ID: 27012024 [No Abstract] [Full Text] [Related]
9. Case report of capecitabine toxicity and use of uridine triacetate. Oliver WD; Duffy AP; Hausner PF J Oncol Pharm Pract; 2019 Mar; 25(2):470-473. PubMed ID: 28942723 [TBL] [Abstract][Full Text] [Related]
10. Eruptive palmoplantar lesions induced by capecitabine: report of a case evaluated with dermoscopy. García-Lozano JA; Ocampo-Candiani J; González-Ramírez RA Cir Cir; 2019; 87(S1):38-42. PubMed ID: 31501632 [TBL] [Abstract][Full Text] [Related]
12. [Toxic dermatitis due to capecitabine: presentation of 2 cases and literature review]. Gutiérrez-Pascual M; Sols-Candela M; Pinedo F; López-Estebaranz JL Actas Dermosifiliogr; 2009 May; 100(4):336-8. PubMed ID: 19463243 [No Abstract] [Full Text] [Related]
13. Photosensitive lichenoid drug eruption to capecitabine. Walker G; Lane N; Parekh P J Am Acad Dermatol; 2014 Aug; 71(2):e52-3. PubMed ID: 25037814 [No Abstract] [Full Text] [Related]